Clinical Trial Update: Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of Phase 1/2 studies evaluating Combretastatin A4 Phosphate in patients with neovascular age-related macular deg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Choroidal Neovascularization

Drugs mentioned

• Combretastatin A4 phosphate (combretastatin A4 phosphate)

Snippet

Sponsor: Johns Hopkins University | Conditions: Combretastatin A4 Phosphate, Age-related Macular Degeneration | Phase 1, Phase 2 | Status: COMPLETED